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ABSTRACT 
 
Background 
Access to dialysis and transplantation in Africa is very limited. The challenges vary in 
different countries across the continent from legislative, to political, to financial. 
 
Aim 
To assess factors influencing the development of organ donation and transplantation 
in the African context. 
 
Methods 
A structured interview was held with African delegates attending the 25th Southern 
African Transplantation Society Congress and Global Alliance for Transplantation 
Workshop in Durban from the 28th July to 2nd of August 2013. Data from workshop 
working group presentations for each African country were additionally analysed. 
 
Results 
30 delegates from 10 African countries (Cameroon, Ethiopia, Ghana, Kenya, Malawi, 
Nigeria, Rwanda, Tunisia, Sudan and Zambia) participated in the working groups. 
Twenty-eight questionnaires were completed. The burden of disease and challenges 
were large and varied. With marked disparity between countries where kidney 
transplantation is paid for entirely out-of-pocket—such as Ghana, Kenya, and Nigeria 
(kidney transplant rates in 2012 of 0.1, 1.4 and 0.1 per million population 
respectively)—and countries where costs are covered by the government or by 
insurance schemes—such as Sudan and Tunisia (kidney transplant rates of 5.3, and 
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11.5 per million population, respectively). For most countries, the cost of 
immunosuppressive drugs and the ability to perform adequate matching of donors 
and recipients were the main infrastructure concerns. Five countries (Cameroon, 
Nigeria, Ghana, Ethiopia, Zambia) did not have legislation governing organ 
transplantation. 
 
Conclusion 
There is need for major political transform which will to ensure that African 
populations achieve access to transplantation. This would allow international 
collaboration and willing local clinicians a framework within which to develop 
sustainable transplant systems.  
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LITERATURE REVIEW 
 
INTRODUCTION 
 
Transplantation is an unavailable therapeutic option for millions of African patients 
with end stage organ failure.  
 
An effective transplant program requires legal and government backing, financial 
support and effective healthcare infrastructure which includes medical personnel, 
laboratory and hospital facilities. The WHO and various international societies 
advocate that each country develop a national strategy for organ donation and 
transplantation.(1, 2) Apart from helping the local population, this self-sufficiency in 
organ transplantation helps to combat organ trafficking and transplant 
commercialism.(3) 
 
Transplantation in Africa is limited to a few countries. Only Morocco, Tunisia, Egypt 
and Sudan in North Africa and South Africa in sub-Saharan Africa have established 
transplant programs. Deceased donation is only practiced in South Africa. 
 
The burden of non-communicable diseases in Africa is increasing.(4) End stage 
kidney disease has been identified as a public health concern.(5) In Sub-Saharan 
Africa chronic kidney disease primarily affects young adults in their economically 
productive years unlike in the developed world where it typically affects middle-aged 
and elderly populations.(6)  
 
 4 
 
Renal failure is the most common type of end organ failure that can benefit from 
transplantation. Renal transplantation is the treatment modality that offers the best 
quality of life and is in most contexts more cost-effective than long-term dialysis. 
Living kidney donation is an established donor source and the kidney is the most 
accommodating organ in terms of warm and cold ischaemia from deceased donors.  
 
End stage kidney disease alone can be estimated through modelling studies to affect 
400 cases per million population in sub-Saharan Africa.(7-9) The prevalence of HIV 
associated kidney disease, particularly in sub-Saharan Africa, also adds to the 
burden of ESKD. HIV associated kidney disease is reported at 6% in South Africa, 
24% in Kenya, 34% in Zambia and 38% in Nigeria.(10) HIV also leads to exclusion of 
living organ donors and deceased donors. Except in South Africa, where an HIV+ to 
HIV+ program is in place for deceased donors who test positive.(11) Governmental 
action is required to treat what is a public health threat on all levels: from prevention, 
to access to dialysis and transplantation.(12) There is however a paucity of renal 
registry data to inform health policy which has been identified as an area desperately 
requiring address by numerous authors.(13, 14) 
 
While various efforts have been made to help develop transplantation in Africa it has 
been limited by various factors in different countries.(15) Training opportunities and 
outreach from large international societies such as the International Society of 
Nephrology (ISN) have helped increase awareness to some degree in sub-Saharan 
Africa.(4) Despite efforts such as this the fact remains that vast majority of ESKD 
patients in sub-Saharan Africa discontinue treatment and die.(16) 
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The Global Alliance for Transplantation (GAT) is a partnership between The 
Transplantation Society (TTS) and the World Health Organization (WHO) aimed to 
help countries develop transplantation through the support of the international 
community. 
 
COUNTRY SPECIFIC TRANSPLANT LITERATURE REVIEW 
 
CAMEROON 
 
There have been no reports of successful solid organ transplants in Cameroon. 
There are no reports of public or health care worker views towards organ donation 
and transplantation. 
 
Renal replacement therapies have been available since the 1980s with  
successful ambulatory peritoneal dialysis reported in Cameroon in 1985.(17) 
Haemodialysis was also started with twice weekly dialysis sessions for 54 patients in 
2008 with 12 dialysis machines.(18) This was for a population of 18 million people. 
The burden of end stage kidney disease has grown and a series of 518 AV fistulas 
over 7 years was reported in 2010.(19) Currently peritoneal dialysis is no longer 
available in Cameroon. A nutritional study of 113 patients undergoing haemodialysis 
over a 6 month period highlighted that 28% were underweight, 21% had objective 
muscle wasting, 31% had a low albumin and 83% were anaemic.(20) The same 
author has reported on mortality rates over a 10 year period from 2002 to 2012. In 
this study 88.8% of patients had an unplanned initiation of dialysis with 25% dying 
within the first year. Median survival was 3 years with 66% of patients being male 
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with a median age of 47 years at the start of dialysis.(21) In 2017 a multicentre study 
prospective cohort study published over a 15 month period showed a median 
survival of only 8 months and concluded that in a country where 95% of dialysis 
patients receive a government subsidy to start dialysis improvements were 
necessary.(22) 
 
ETHIOPIA 
 
There have been no reports of successful solid organ transplants in Ethiopia. There 
are no reports of public or health care worker views towards organ donation and 
transplantation. There have been some reports on corneal donation with 37% in a 
single study reporting a willingness to donate their eyes. This was correlated with a 
religious belief of Christianity and a higher education level of high school.(23) In a 
similar study looking at attitudes towards corneal donation in health science students 
religion, be it “church going” or Muslim, was seen as a significant influence to not 
donate.(24) 
 
The first published report of dialysis in Ethiopia was in 1994 with 118 cases of acute 
renal failure requiring renal support. Septic abortion (71 patients) and malaria (29 
patients) were the leading causes of renal failure.(25) 
 
The next available report is of a dialysis service started at Bethel Hospital in 2008 
funded through international support and a non-profit foundation.(26) Dialysis had 
been available in the private sector since the early 2000s. The cost was estimated to 
be $100 per session, this in a country with a per capita GDP of $161 in 2005. A more 
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recent publication put the cost of a year of dialysis at $10 680 with a renal transplant 
estimated to cost $ 20 000.(27)  In a study from a private centre, Saint Gabriel 
General Hospital, a total of 191 patients were offered dialysis over an 8 year period 
from 2002 to 2010. Of the 91 patients analysed from this cohort only 42% of patients 
survived longer than a year. Transplantation was sought by 9 patients, who all 
travelled abroad. Ten patients left the country to continue treatment and 7 patients 
transferred to other centres in Ethiopia during the study period.(28) In August 2013 a 
public dialysis unit was opened in Saint Paul's Hospital Millennium Medical College 
in Addis Ababa but this services only acute kidney injury patients. This study did not 
report any patients going on to end-stage kidney disease requiring maintenance 
dialysis.(29) 
 
GHANA 
 
Dialysis has been available in Ghana since 1972 with a report of 92 patients dialysed 
over a 7 year period from 1972 to 1979.(30) In a 20 year review published in 1996 
from the same centre the authors argued for expanding dialysis support in view of 
their 68% survival rate.(31)  
 
That patients travel from Ghana for transplantation is evident from a report published 
in 1998 of a heart transplant in a Ghanaian man who developed Kaposi’s sarcoma 3 
months after a heart transplant.(32) 
 
There have been strong links with Ghanaian centres from the developing world in an 
effort to improve healthcare since the mid-1980s. This began initially in haematology 
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in 1986 between the School of Medical Sciences, Kwame Nkrumah University of 
Science and Technology in Kumasi and St George’s Hospital Medical School in 
London followed by Infectious diseases, microbiology, paediatrics and ultimately 
nephrology in 1995. In 1999 there was no haemodialysis available at this centre and 
this international collaboration resulted in 4 nurses being trained in haemodialysis at 
St George’s Hospital and their returning to work at Komfo Anokye Teaching 
Hospital.(33) 
 
In 2009 a study from Kumasi reported 40 patients who underwent dialysis from 
October 2006 to December 2007. The 1000 bed (2nd biggest) hospital had 5 dialysis 
machines. A 36% mortality was reported. Only 50% of patients were able to afford 
20 sessions of dialysis.(34) Peritoneal dialysis is offered for acute renal failure in 
Kumasi since 2010 and in Accra since 2014. The first $216 of treatment is covered 
by the government and thereafter by the patient or their family. An outreach program 
by Saving Young Lives program, a partnership between the international Society of 
Nephrology (ISN), International Paediatric Nephrology Association (IPNA), 
International Society for Peritoneal Dialysis (ISPD) and Sustainable Kidney Care 
Foundation (SKCF) continues to support the development of peritoneal dialysis in 
West Africa. Limited referral of patients was seen as a limitation on the program to 
develop peritoneal dialysis.(35) A review of dialysis services in 2015 reported 3 
public and 3 private dialysis centres all located in the south of the country (in the 
north 2/3 are not covered) with the author commenting that expanding peritoneal 
dialysis would help to counter an erratic electricity supply.(36) 
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Some studies have looked at attitudes towards donation in Ghana. Although 60% of 
the respondents (who were primarily commuters) had a tertiary level education only 
50% had heard of organ donation. Only 60 % indicated a willingness to 
receive/donate an organ. Reasons given for non-acceptance of organs was cost 
(19%), religious beliefs (30%), medication side effects (21%) and personal feelings 
(26%).(37) In a study of eye clinic patients in Accra 8% were aware of eye donation 
with 60% of respondents indicating a willingness to donate.(38) In 2017 Boima 
looked at 480 respondents from sub-urban Ghana to assess their views on organ 
donation and transplantation. The respondents were from the general public in a 
major city and well educated. Although 71% were willing to donate their kidneys after 
death when they were questioned about the method of determination of death only 
41% were willing to donate after brain death and 60% after cardiac death. A higher 
number (85%) were willing to accept a kidney.(39) In a paper exploring cultural 
aspects of donation the importance of “ancestorship” was explored in the Ghanain 
setting as a way in which cultural support for organ donation could be achieved if it 
was handled in a culturally sensitive manner.(40)  
 
“Ancestorship is a reputational issue of great cultural and existential importance in 
the Ghanaian socio-cultural setting. As such it imposes a unique obligation on 
families at custom that cannot cavalierly be dismissed as non-person affecting and 
may pose a challenge to conscription of deceased organs in that socio-legal context. 
However, crafting a socio-culturally sensitive regulatory framework does not 
necessarily preclude the donation of (deceased) human biomaterials for transplant 
and science research. Indeed, when the contextual issues are explored with open-
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mindedness and sensitivity it can be shown that such donation can form part of the 
important customs of some communities in this jurisdiction.”(40) 
 
Transplantation Links, a UK based charity supporting transplantation in the 
developing world, has supported the development of living related renal 
transplantation in Ghana since 2007. This has taken the form of 1 scoping visit, 5 
transplantation visits and a Ghanaian surgeon work placement at University Hospital 
Birmingham for 6 months. Transplantation visits involve performing live donor 
transplants, both adult and paediatric. One year survival across all centres is 
reported at 90%.(15) Longer term data is not available from any African centre 
(includes Nigeria, Kenya and Zambia) involved with this group. The data is held 
locally and although “encouraged to publish” there is no peer reviewed publication of 
the outcomes of any transplants from these countries. Specialist skills transferred 
include transplantation surgery (adult), nephrology (adult), anaesthesia, adult renal 
nursing, operating theatre practitioners, transplantation program management. 
 
A total of 17 living related kidney transplants have been performed in Ghana since 
2008.(36)  
 
With a view to assessing the need for liver transplantation a 7-year review from 2007 
– 2013 looked at all patients diagnosed with hepatocellular cancer and their 
treatment options as per the Barcelona Clinic Liver Cancer algorithm. Of 465 
patients 206 charts were available for review and 118 had enough information to 
complete BCLC staging. Of 465 patients 50% died on the admission HCC was 
diagnosed. Only 8% were eligible for resection, transplantation or ablation.(41)  
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KENYA 
 
The first report of a renal transplant in Kenya was in 1980.(42) In a 2 year period 
from 1984 to 1986, 77 patients were offered haemodialysis with a view to 
transplantation. The mean age was 29 years and the mean duration of dialysis was 
2.9 months. Of 4 patients transplanted 2 were successful with the other 2 patients 
dying. Only 14 patients were still on dialysis at the end of the study period.(43) When 
a 5 year review was performed of 20 patients transplanted only 12 were alive 1 year 
post transplant.(44) 
 
By 1996 results had improved with Kayima et al. reporting one year graft and patient 
survival rates were 93% and 86.6% respectively. The second year graft survival 
rates remained at 93% and the patient survival rate was 80%. Complications were 
primarily bacterial (69%) and 7 patients had acute rejection. The majority of donors 
were siblings.(45) In 2003 there were 100 patients on haemodialysis at Kenyatta 
National Hospital.(46) 
 
Attitudes towards xenotransplantation in Kenya were reported in 2001 as part of a 3 
centre study. Of note 83% of Kenyan students were religiously active (compared to 
Sweden 10% and Texas, USA 59%) and this was associated with a lower 
acceptance rate of xenotransplantation. Vegetarians were also less accepting.(47) 
 
In a 2007 study looking at attitudes towards donation of umbilical cord blood 
amongst recent mothers only 66% felt they could make the decision to donate alone 
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despite 81% being in favour of donating and 78% prepared to have their child 
receive a transfusion. 90% of women were prepared to undergo HIV testing if they 
were to donate. 
 
MALAWI 
 
Dialysis (haemodialysis and peritoneal) was available in Malawi in the 1980s but 
results were poor due to an inability to purify tap water to dialysis water. By 1994 
dialysis was no longer available with patients travelling to South Africa for dialysis. 
In1998, 4 machines and a water –purifying system were purchased and staff sent to 
South Africa for a 1 week training course. In 2 years, 29 patients (58% male) were 
dialysed. 8 of these were chronic renal failure patients. There were 10 deaths (2 in 
the chronic renal failure group).(48) 
 
Malawi is rated 165 out of 177 in the human development index and as such is one 
of the poorest countries in the world. A paper in 2007 looked at the laboratory costs 
involved for Malawi to adopt the WHO endorsed system of voluntary unpaid blood 
donation. In sub-saharan Africa the lack of such services means that 80% of blood 
donors are sourced from families at local hospitals. Of 1729 donors only 1104 
resulted in blood collection; 275 were excluded for being anaemic, 175 were HIV 
positive, 38 were VDRL positive, 21 had Hep B and 102 had malaria smear positive 
(35.4% were rejected). The laboratory cost was $56 per unit of blood in a country 
with a per capita GDP of $320.(49) A year of dialysis is estimated in 2016 to cost $20 
000 in Malawi.(50) 
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In correspondence to the Lancet in 2015 Bates et al, note that while dialysis is 
offered to 60 patients at two different centres in Malawi the reality of the situation is 
that the inclusion of the palliative care team for these patients is the major treatment 
pathway given that so many will not access dialysis after their diagnosis.(51) 
 
In 2016, a look at health-related quality of life of haemodialysis patients was 
published because standard laboratory monitoring of dialysis effectiveness is not 
done. The Kidney Disease Quality of Life Instrument was used with the physical 
health scores reported as particularly low (59.9 out of 100) which was postulated to 
affect income generating capacity.(50) A further study looked qualitatively at 10 
patients with end stage renal failure not able to be dialysed for “health systems 
issues”. The major issues for these patients were functional decline, financial 
challenges, loss of role in the family and spiritual and cultural beliefs. A sense of the 
health care system letting the patients down was not reported.(52) 
 
Evans et al reported in 2017 on a pragmatic cohort of all medical admissions over a 
2 months period. Of 892 patients screened 153 had AKI. 58.8% of whom had HIV. A 
total of 21 patients (13.7%) had an indication for acute dialysis. 8 patients received 
dialysis with renal recovery in 6 patients after a median of 4 sessions of dialysis. 1 
patient died on active treatment and another had treatment withdrawn. Long term 
follow-up of these patients was not available and although 68 patients had some 
recovery of renal function 43 of these had persistent kidney injury at the time of 
discharge. A total of 128 patients were discharged with abnormal creatinine levels 
and no further record is noted.(53)  
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Worldwide pooled mortality from AKI is 21% and in SSA is 32%. 
 
In a study on traumatic brain injuries over a 3 year period from 2012 to 2015 the 
authors looked at the outcomes of exploratory burrholes necessitated by a lack of 
available CT scanning resources. The authors report a mortality rate of 6.8% but do 
not comment on brain death legislation.(54) 
 
NIGERIA 
 
The first publication related to transplantation in Nigeria was in 1992 which was a 
case study of a 40 year old patient who had received his transplant in the United 
Kingdom and presented with repeated episodes of chronic allograft rejection. This 
patient during admission for one such episode.(55) The first report of haemodialysis 
in Nigeria was of the first 100 sessions at University College Hospital, Ibidan. Of the 
9 patients 6 discontinued therapy due to financial constraints after less than 10 
sessions. There were also multiple technical challenges highlighted with 8 septic 
episodes reported.(56) A subsequent report from the same institution 5 years later 
reported on 158 patients (141 for chronic renal failure) and noted 70.8% were unable 
to afford dialysis for more than a month. Between 1 to 10 new patients presented 
each month to the service and the authors concluded that haemodialysis in a 
developing economy like Nigeria would be subject to “adequate health planning”.(57) 
 
In a study looking at attitudes towards living kidney donation 62% of health workers 
would be willing to donate. This compared to 52.1% of first degree relatives of 
patients with ESRD and 27.1% of people from rural areas who were surveyed. The 
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most commonly cited reason for refusal to donate was fear of adverse health 
consequences.(58) In a subsequent study looking only at 205 health care workers 
(55% of whom were doctors) only 59.3% were willing to donate an organ. “Fear of 
complications” (44.9%) and “mistrust of health sector” (20.6%) were the most 
common reasons for unwillingness to donate.(59) In the largest such study looking at 
public attitudes across Nigeria of 1300 respondents (with 53.2% Muslim) 66% were 
willing to donate a kidney, 25% were not willing and 8.9% were undecided. 
Respondents were asked if incentivization would change their opinion and 99.4% 
said that it would not.(60) A lack of awareness related to religious precepts and trust 
in the health care workers handling the organs was demonstrated in one study 
looking at attitudes towards deceased donation in northern Nigeria.(61) A lack of 
awareness of kidney transplantation was highlighted in another study of health care 
workers and care givers where on 60% were aware that kidney donation existed.(62) 
In a study in 2011 looking at cadavers used for teaching, at over half of the medical 
schools in Nigeria, not one body was bequeathed to scientific research with 90% 
being traumatic deaths and 10% were unclaimed bodies.(63)  
 
Nigeria has been chronically under resourced in terms of dialysis machinery. In 2000 
with a population of 120 million it was estimated that Nigeria had 80 haemodialysis 
machines. The absence of government funding or subsidy was highlighted as a 
problem as well as staff migration to the Middle East and Western world.(64) In a 7 
year review of 320 consecutive renal dialysis patients done in 2012 80% of patients 
funded their dialysis treatment directly out of pocket. The average duration of dialysis 
was 5.2 weeks with the majority (98.1%) unable to sustain dialysis longer than 12 
weeks. One hundred and twenty eight patients died within 90 days of entry into 
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dialysis care leading the authors to conclude that opportunities for kidney 
transplantation would be low.(65) 
 
In 2005 the first series of renal transplants in Nigeria was published. The first patient 
died 6 months after from sepsis while the other 2 patients were well 35 months post 
transplant. The authors commented on major difficulties procuring and monitoring 
immunosuppressive drugs.(66) In a survey of family members of neurosurgical 
patients 22.2% had heard of brainstem death however almost all (98.4%) believed 
that death only occurs when both breathing and heartbeat stop. Although 66.9% 
would donate an organ, and 76.4% would accept an organ 59.8% would not allow an 
organ to be taken from a deceased relative.(67) 
 
Ethical concerns related to the commodification (commercialization) of organ 
transplants are discussed in the Nigerian academic literature with another major area 
of focus being that of truly informed consent for donors and recipients based on local 
outcomes.(68) The lack of legislation regarding deceased donation and 
transplantation as well as the lack of a renal registry was highlighted by Bakari et al. 
in the Nigerian Journal of Surgery in 2012 and by Ajayi et al. in 2016.(14, 69) 
Patients in Nigeria do travel for transplant primarily to India with 54% being living 
unrelated transplants. Over an 8 year period 26 patients travelled abroad for 
transplantation and were then followed up in Nigeria. Short term graft and patient 
survival were poorer than values recommended for living kidney transplants.(70) 
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RWANDA 
 
In Rwanda there are 4 dialysis centres. Three are in the capital city, Kigali and one in 
a rural area in the south of the country. In Rwanda 84% of the 11 million population 
lives in the rural areas. For those undergoing dialysis only 51% (21 patients) were 
adherent to their dialysis regimen. Financial limitations were a major factor to non-
adherence. Transplant was not considered a treatment option for the patients in this 
study even though 12 patients had been on dialysis more than 5 years. (71) 
Technical surgical success rates of arterio-venous fistula (AVF) creation in 31 of 37 
patients assessed for AVF were good at 90% in a study from Rwanda.(72) Blood 
transfusion alone has been noted to be in need of assistance in Francophone 
countries in Africa (which includes Cameroon and Rwanda) with poor levels of 
organization, insufficient supply of blood products, limited financial resources and 
cultural obstacles.(73) 
 
SUDAN 
 
The first renal transplant in Sudan was between 1978 and 1985. In that same period 
39 transplants for Sudanese patients were performed in other countries primarily in 
the United Kingdom (21) and Kuwait (11). Survival at 2 years was 90%.(74) The 
impact of Immunosuppression with cyclosporine (CsA) in 78 Sudanese renal 
transplant patients was published in 2009. Patients had a mean age of 42.1 years 
and had been transplanted a mean of 3.8 years with increased CsA levels in 
hypertensive and female patients and 62.8% of patients having lipid 
abnormalities.(75) 
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In a case report of two Sudanese refugees resettled in the United States who 
underwent liver transplantation the infectious disease considerations were 
highlighted as requiring specialized input. Evidence of exposure to malaria, intestinal 
parasites and tuberculosis were identified in these patients with treatment and 
preventative strategies tailored for the individual patient.(76) The need for malaria 
prophylaxis in transplant recipients has been looked at in a study from Sudan where 
55 renal transplant recipients were followed up and compared to 55 controls. There 
were 25 and 26 malaria attacks diagnosed in each arm in one year of follow-up. 
 
Cost of renal transplantation for both the first (US $14 825.04) and second (US $10 
651.00) year post transplant was higher than a year of haemodialysis 
(US $6 847.00) in Sudan.(77) The authors do note that the haemodialysis regime 
employed in Sudan of 2 sessions per week is not adequate as per the National 
Kidney Foundation Dialysis Outcomes Quality Initiative recommendations(78, 79) 
and the National Cooperative Dialysis Study(80) and as such the difference may be 
less.  
 
The genetic polymorphism of the 3 major tribal groups in Sudan was looked at in 250 
renal transplant donors. There was considerable polymorphism at each locus for 
Gaalia, Johyna and Nile Nubian population groups which the authors commenting 
that the considerable heterogeneity in Class I and II polymorphisms reflects recent 
admixture of these groups with local Arab and African populations.(81) 
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A report on Sudanese victims of organ trafficking in Egypt is available online with 
video testimonies from 12 individuals. 57 Sudanese refugees and asylum seekers 
were reported to be the victims of illegal removal of a kidney. In 9 of the 57 cases 
they were simultaneously trafficked for sex. In depth interviews were conducted with 
12 victims. In 3 of these cases the organ traffickers had assisted in smuggling the 
victims into Egypt.(82) 
 
TUNISIA 
 
Tunisia has a long history of providing renal transplantation with the first case in 
1962. A national registry was formed in 1962. In 1968 a comprehensive dialysis 
program was setup. A renal failure association was setup in 1982 and a national 
society of nephrologists in 1983. A national registry in 1986. The incidence of renal 
replacement therapy increased from 13 per million population (pmp) in 1986 to 133 
per million population in 2008. There are five nephrology departments across 
university hospitals and strict government criteria regulating dialysis centres.(83) 
 
Tunisia reports data to Middle Eastern Society of Organ Transplantation (MESOT). 
This organization collects data on transplant activity from Middle Eastern countries 
since 2002. Tunisia has both a deceased donor and a living related 
program.  Through the end of 2003, 155 cadaveric and 350 living-related kidney 
transplants had been performed in Tunisia. Thirty of these kidney transplants had 
been performed outside the country. Limited numbers of liver (16), heart (14) and 
bone marrow transplants (196) had been performed.(84) In 2014 is was estimated 
that Tunisia spends 7% of the gross national product on health.(85) 
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The first transplant was performed in 1986 with that centre recently publishing its 30 
year experience in 702 renal transplants. Before that time it is estimated that 120 
Tunisians had travelled abroad for transplants covered by the government and social 
funding. The mean age of recipients was 32.7 +/- 11.5 (rage 6 – 65 years) with a 
gender ratio of 2.2: 1 in favour of males. The majority of donors were living (78.8%) 
with deceased donors accounting for 21.2% of kidneys. In a subset analysis the 
authors noted that deceased donation fell from 27.4% of donor kidneys in 2006 – 
2010 to 12.9% in the period 2011 – 2015. Outcomes were good from this single 
centre with patient survival rates at 1, 5, 10 and 20 years being 96%, 89.3%, 79.5% 
and 65.4%. This centre conducts 42% of all renal transplants in Tunisia.(86) This 
centre published the outcomes from the first 144 donors in 1997 and reported some 
intraoperative challenges, no deaths and minor morbidities that were commented to 
be slightly higher than United States rates at the time.(87)  
 
Tunisia is predominantly a Sunni Muslim country with deceased donor corneal 
transplants allowed by religious leaders since 1959 in Tunisia. The International 
Islamic Jurist Council recognized brain death in October 1986. This was followed by 
the International Islamic Fiqh Academy and the Islamic Fiqh Academy issuing 
important fatwas on organ transplantation in 1990 and 2003.(88) In Tunisia 
transplants occurred without legal statute as brain death and transplantation 
legislation was only passed in 1991. In 1995 Tunisia formed a national coordination 
body responsible for overseeing organ donation and transplantation.(89) Subsequent 
to this the Tunisian Islamic authority now supports donation and public hospitals are 
exclusively authorized to perform transplants with financial compensation for organ 
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donation strictly prohibited.(86) Tunisia is the only Islamic country in North Africa with 
a deceased donor transplant program.(90) 
 
Two papers have covered tuberculosis in transplant recipeints. In the first 5 renal 
transplants recipients were diagnosed with TB over a 22 year period. In one case 
this was disseminated disease leading to the death of the patient and in 3 patients it 
recurred. The incidence however was no greater than the 1% recorded in the 
general population.(91) In another series over 25 years an incidence of 3.2% was 
reported. Mortality was 12.5% (2 of 16 patients).(92) 
 
There is a good body of published research from Tunisia looking at impact of 
multiple arteries in the donor kidney(93), vasculitis(94), polycystic kidney disease, re-
hospitalization rate(95), factors influencing long term (>15 years) outcomes(96), 
organ trafficking(78), and post-transplant diabetes(97). In the study looking at re-
hospitalization rate in the first year after transplant was 45.5% with infections 
accounting for 55% of admissions and renal dysfunction 26% with an median length 
of stay around 15 days.(95) In the study looking at organ trafficking 20 patients had 
travelled to Iraq (14), Egypt (3) and Pakistan (3) with a high incidence of surgical 
complications reported.(78) The short-term and long-term outcome of living kidney 
donors has been looked at with minimal procedural complications reported and no 
deaths and good long term outcomes with 52% follow-up. In this 30 year 
retrospective review 20.4% of donors had become hypertensive and 8.4% had 
become diabetic although renal function was preserved and the authors stressed the 
need for good follow-up.(98) 
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ZAMBIA 
 
There have been no reports of successful solid organ transplants in Zambia. There 
are no reports of public or health care worker views towards organ donation and 
transplantation. There are no published reports of dialysis facilities in Zambia. 
 
INTERNATIONAL COLLABORATION PROJECTS 
 
Transplant Links, founded in 2006, is a UK based charity with volunteers primarily 
from University of Birmingham, who together with African colleagues aim to perform 
between 2 – 4 renal transplants in a one-week period in the local country. The 
largest amount of work has been done in Ghana but this group has also performed 
outreach to Nigeria and to Trinidad.(99) 
 
In Cameroon a dialysis unit is maintained through the World Organization of Renal 
Therapies (WORTH) with plans for further expansion.(100) 
 
SUMMARY OF LITERATURE REVIEW 
 
The level of health care infrastructure varies markedly between the countries 
reviewed. In some countries (Cameroon and Ghana) despite dialysis being available 
for some time there has been very limited progress towards establishing transplant 
programs. Financial limitations are a repeated concern in accessing dialysis services 
across the continent. In countries where the dialysis service has grown to service 
sufficient numbers of patients transplantation has been more actively pursued. 
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Overall there are relatively few publications from African countries on issues related 
to dialysis and transplantation. The quality of data reported is poor with research 
being driven by isolated research projects rather than coming as a spin-off from large 
national registries informing health care practice. 
 
Public awareness of organ donation is limited even amongst families members of 
patients with organ failure and healthcare professionals. In Zambia there is no 
published literature related to dialysis, organ donation or transplantation. 
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AIM 
 
To assess factors influencing the development of organ donation and transplantation 
within the African context. 
 
METHODS 
 
A structured interview was held with African delegates attending the 25th Southern 
African Transplantation Society Congress and Global Alliance for Transplantation 
Workshop in Durban. Interviews were performed by a single interviewer for 30 
minutes over a 4-day period from 29 July - 2 August 2013 with a standardized 
questionnaire completed (Appendix 1).   
 
Delegates for the conference were selected on the basis that they were from English 
speaking countries identified to benefit the most from forming partnerships with the 
International Society of Nephrology (ISN) and the Transplantation Society (TTS). A 
list of 31 interested clinicians from 10 countries was compiled based on discussions 
held at the 12th Congress of the African Association of Nephrology in Accra, Ghana 
on 20th - 23rd February 2013. Clinicians with previous nephrology training through 
ISN and surgeons tasked with performing transplants were selected. 
 
The questionnaire covered respondent details, their local staffing infrastructure, 
hospital infrastructure, drug availability, financial support and views on international 
collaboration and training. Perceived country specific barriers to living donor 
transplantation, deceased donor transplantation, successful transplant outcomes and 
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transplantation in general were assessed on a 10 point Likert scale, with 1 being of 
least important and 10 being the most important. 
 
Working group presentations presented during the Global Alliance for 
Transplantation Workshop - by representatives of each country - were prepared 
following small group sessions according to a template (Appendix 2) and aimed to 
assess activity in each country and identify key aspects to improving transplantation 
in each country. The presentations covered transplantation and dialysis activity, 
number of transplant centres, infrastructure, waiting lists and laws and legal 
regulations for each country represented. 
 
Verbal consent was taken from each delegate taking part in the interview and 
completion of a questionnaire, and participation was on a voluntary basis. That the 
questionnaire was part of a research project was expressly stated. Presentations 
during the Global Alliance for Transplantation Workshop were for the purpose of 
compiling information to help further develop transplantation in Africa in country 
specific terms and consent was given for such information to be published. 
 
The study was approved by the University of Cape Town, Department of Surgery 
Research Committee project number 2013/132 and by the Human Research Ethics 
Committee of the University of Cape Town 594/2014. 
 
Descriptive statistics were used to present the data.  Continuous variables were 
summarized as means and standard deviation (SD) or median with interquartile 
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range if data is not normally distributed.  Categorical variables were summarized as 
frequencies and percentages. 
 
Data were entered into Microsoft Excel spreadsheet and variables analyzed on an 
individual and a country basis. For countries with multiple delegates completing 
interviews the Likert scale answers for barriers to living donation, deceased 
donation, transplant outcome monitoring and national transplant programs were 
summarized as means and standard deviations in order to draw comparisons 
between countries. All analysis was conducted in Stata statistical software version 
15.1 (Stata Corp, College Station, TX). 
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RESULTS 
 
30 delegates from 10 African countries attended the Global Alliance for 
Transplantation Workshop and South African Transplant Society Meeting from the 
28th July to 2nd of August 2013.  
 
African countries represented were Cameroon, Ethiopia, Ghana, Kenya, Malawi, 
Nigeria, Rwanda, Sudan, Tunisia and Zambia with a total of 20 different hospitals 
represented. (Figure 1: African Countries Participating in Global Alliance in 
Transplantation Workshop – Dialysis and Transplantation Activity 2012)  
 
All 30 delegates participated in compiling the working group presentations specific to 
their country and 28 delegates completed a 30 minute structured interview with the 
researcher. 
 
Delegates completing the questionnaire were majority male (25) with only 3 female 
doctors represented. Twenty-two were physicians or nephrologists (78.5%), 2 were 
urologists (7%), 1 cardiothoracic surgeon (3.5%), 2 surgical trainees (7%) and 1 
immunologist (3.5%). The majority of delegates were from Nigeria (12) followed by 
Kenya (4) and Zambia (3), there were 2 delegates from Ethiopia and Ghana and 1 
each from Cameroon, Malawi, Rwanda, Sudan and Tunisia. 
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Figure 1: African Countries Participating in Global Alliance in Transplantation 
Workshop – Dialysis and Transplantation Activity 2012 
 
 
 
 
There were no more than 3 delegates from a single institution from the total of 20 
institutions represented. (Table 1: Institutions and countries represented at the 
Global Alliance for Transplantation workshop) 
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Table 1: Institutions and countries represented at the Global Alliance for 
Transplantation workshop 
 
Institution Country Number of delegates 
Yaounde General Hospital Cameroon 1 
Black Lion Hospital Ethiopia 1 
School of Medicine, Addis Ababa Ethiopia 1 
Korle Bu Teaching Hospital Ghana 1 
University of Ghana Ghana 1 
Kenyatta National Hospital Kenya 2 
Maseno University Kenya 1 
Moi Teaching and Referral Hospital Kenya 1 
QE Central Hospital Malawi 1 
Aminu Kano Teaching Hospital Nigeria 2 
Obafeni Arolomo University Nigeria 1 
St Nicholas Hospital Nigeria 1 
University College Hospital, Ibadan Nigeria 2 
University of Ilorin Teaching Hospital Nigeria 3 
University of Nigeria Teaching 
Hospital 
Nigeria 2 
Yariman Bakura Specialist Hospital Nigeria 1 
King Faisal Hospital Rwanda 1 
Dr Salma Centre for Kidney Disease Sudan 1 
Charles Nicolle Hospital Tunisia 1 
University Teaching Hospital, Lusaka Zambia 3 
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Half of respondents had worked for 10 years or less at their current institution, but 
the majority had completed their undergraduate medical training locally (22 / 78.5%), 
3 people (10.7%) had trained elsewhere in Africa and 3 people (10.7%) had trained 
overseas. All but 1 delegate had completed postgraduate training with 24 of these 
being locally trained (85.7%), 2 (7.1%) had specialized elsewhere in Africa and 2 
(7.1%) had specialized overseas. Most (23 / 82.1%) of the delegates had travelled 
abroad for some form of further training. The primary salary source for the 
respondents was from the national government (22 / 78.5%) with 2 (7.1%) being 
university employees and 4 (14.2%) primarily privately funded. The monthly salary 
was under $1500 for over half (60.7%) of respondents. Twelve (42.8%) 
supplemented their salary with additional private work and for 3 delegates this made 
up over half their monthly income. (Table 2: Respondent information) 
 
Table 2: Respondent details  
 
Total respondents 28 
Gender  
  Male 25 
  Female 3 
Undergraduate training  
  Locally trained 22 (78.5%) 
  Trained elsewhere in Africa 3 (10.7%) 
  Overseas 3 (10.7%) 
Postgraduate training  
 Yes 27 (96.4%) 
  No  1 (3.5%) 
Postgraduate training institution    
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  Locally trained  24 (85.7%) 
  Trained elsewhere in Africa 2 (7.1%) 
  Overseas 2 (7.1%) 
Other training abroad   
  Yes  23 (82.1%) 
  No 5 (17.8%) 
Years at current institution  
  0 - 10 14 (50%) 
  11 -15 2 (7.1%) 
  16 - 20 7 (25%) 
  21 - 25 3 (10.7%) 
  > 25 2 (7.1%) 
Teaching role at institution  
  Yes 26 (92.9%) 
  No 2 (7.1%) 
Salary source  
  Government 22 (78.5%) 
  Private 4 (14.3%) 
  University 2 (7.1%) 
Salary level (monthly)  
  $ 1000 -1500 17 (60.7%) 
  $ 1500 - 2500 7 (25%) 
  Unsure 4 (14.3%) 
Percentage of income from private work    
  None  16 (57.1%) 
  0-25% 6 (21.4%) 
  25-50% 3 (10.7%) 
  >50% 3 (10.7%) 
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Staffing Support 
 
All respondents reported that surgeons, nephrologists and anaesthetists were 
available at their centre. The absolute number did vary but most respondents had 
between 2 - 4 surgeons (n = 19), 2 - 4 nephrologists (n = 15) and 2 - 4 anaesthetists 
(n = 11) able to support transplantation. Four respondents would have to rely on less 
than 2 surgeons and 2 respondents would have to rely on less than 2 anaesthetists. 
 
Specialized nursing support was available in the form of ICU nurse specialization 
according to 10 respondents. Most (n = 23) reported that nephrology was available 
as a specialization for nurses as well as transplant coordinators (n = 18). (Table 3: 
Staffing support for transplant services) 
 
Table 3: Staffing support for transplant services 
 
Doctors  
 Surgeons able to support 
transplantation 
- < 2  
- 2 - 4 
- > 5 
 
4 
19 
5 
  Nephrologists 
- < 2 
- 2 - 4 
- > 5 
 
5 
15 
8 
  Anaesthetists 
- < 2 
- 2 - 4 
- 5 - 9 
- > 10 
 
2 
11 
7 
6 
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Nursing  
  ICU Specialization 
- Yes 
- No 
 
10 
18 
  Nephrology specialization 
- Yes 
- No 
 
23 
5 
  Transplant coordinator 
- Yes 
-  No 
 
18 
10 
 
 
Hospital Infrastructure 
 
Respondents reported on laboratory support, pathology services, radiological 
services, operative and peri-operative support, infection prevention and the ability to 
mechanically ventilate brain dead donors.  
 
Most basic laboratory services required by transplantation were available. However 
over 25% of respondents did not have access to laboratory microalbuminuria testing, 
24-hr ambulatory BP monitoring and CMV viral load monitoring. Just over half 
(53.6%) had pharmacology services available for therapeutic drug level monitoring. 
 
All but 2 respondents reported the capability to perform renal biopsies, however 
28.6% were worried about the ability to interpret acute rejection at their centre. 
CT Scanning was widely available. Only 1 centre in Malawi did not have a CT 
scanner available. They were of varying resolution. Radiological interventions for 
treating potential transplant complications such as percutaneous nephrostomy and 
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cystoscopy and stenting were available to most respondents. Nuclear medicine 
studies were only available to 53.6% of respondents. 
 
Theatre availability was 24 hours at all centres. Epidural anaesthesia was available 
in all but 1 centre. Laparoscopic surgery was available to 72.4% of respondents with 
just under half (46.4%) already performing nephrectomies laparoscopically. Most 
(92.3%) of respondents would have availability of isolation rooms for transplant 
recipients. 
 
Infection prevention committees were active for 85.7% of respondents. And although 
Hepatitis B and Yellow fever vaccines were widely available (96.4% and 89.3% 
respectively) pneumovac was less available with only 57.1% of respondents having 
access. 
 
While 23 (82.1%) of respondents reported the ability to ventilate a brain dead patient 
for 24 hours ICU resource limitations meant that only 19 (67.9%) would be able to 
extend that period to 48 hours. 
 
Basic internet access was available in all but 1 centre although 25% reported that 
their internet access was not of sufficient quality to support video calling. (Table 4: 
Hospital Infrastructure) 
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Table 4: Hospital infrastructure for transplant services 
 
Laboratory services Available Not available 
Daily creatinine 27 (96.4%) 1 (3.4%) 
GFR estimations 27 (96.4%) 1 (3.4%) 
Microalbuminuria 21 (75%) 7 (25%) 
24 hr BP monitoring 19 (67.9%) 9 (32.1%) 
HIV 27 (96.4%) 1 (3.4%) 
Hep B sAg 28 (100%) 0 (0%) 
Syphilis 27 (96.4%) 1 (3.4%) 
CMV viral load 21 (75%) 7 (25%) 
Infective blood screening results in 24 hrs 22 (78.6%) 6 (21.4%) 
Blood bank 27 (96.4%) 1 (3.4%) 
Pharmacology lab 15 (53.6%) 13 (46.4%) 
Pathology services          
Renal biopsy 26 (92.9%) 2 (7.1%) 
Able to diagnose acute rejection 20 (71.4%) 8 (28.6%) 
Radiology   
CT scanner       27 (96.4%) 1 (3.6%) 
Resolution of CT Scanner (No. of slices) 
- 8 
- 16 
- 32 
- 64 
- unsure 
 
- 2 (7.1%) 
- 6 (21.4%) 
- 3 (10.7%) 
- 7 (25%) 
- 9 (32.1%) 
Ultrasound 28 (100%) 0 (0%) 
Nuclear medicine studies 15 (53.6%) 13 (46.4%) 
Percutaneous nephrostomy 25 (89.3%) 2 (7.1%) 
Cystoscopy & stenting 26 (92.9%) 2 (7.1%) 
Operative & perioperative care   
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24 hour operating rooms available   
Epidural anaesthesia 27 (96.4%) 1 (3.6%) 
Laparoscopic surgery 20 (72.4%) 8 (28.6%) 
Level of laparoscopic operations 
- Cholecystectomy 
- Colectomy 
- Nephrectomy 
 
18 (64.3%) 
4 (14.3%) 
13 (46.4%) 
 
6 (21.4%) 
17 (60.7%) 
12 (42.9%) 
Isolation rooms 26 (92.3%) 2 (7.1%) 
Infection prevention   
Infection control committee 24 (85.7%) 4 (14.3%) 
Vaccinations available 
- Hepatitis B 
- Yellow fever 
- Pneumovac 
 
- 27 (96.4%) 
- 25 (89.3%) 
- 16 (57.1%) 
 
- 1 (3.6%) 
- 3 (10.7%) 
- 12 (42.9%) 
Mechanical ventilation for donors   
Ability to ventilate brain dead patient for 24 hrs 23 (82.1%) 5 (17.9%) 
Ability to ventilate brain dead patient for 48 hrs 19 (67.9%) 9 (32.1%) 
Internet access         
Basic internet access 27 (96.4%) 1 (3.6%) 
Bandwidth to support video calls 21 (75%) 7 (25%) 
 
 
Drug availability 
 
Immunosuppressive drugs were not available to all respondents. The most 
commonly available drugs were methylprednisolone, cyclosporin, mycophenolate 
mofetil and azathioprine. Tacrolimus was available to 64.3% of respondents. Other 
immunosuppressives such as anti-thymocyte globulin, thymoglobulin and rituximab 
were not readily available, with less than 14.3% of respondents having these drugs 
available. Seventeen (60.7%) of respondents had immunosuppression protocols in 
 37 
 
place with 9 of these (52.9%) using tacrolimus and 8 (47.1%) cyclosporin as their 
primary calcineurin inhibitor. Plasmapheresis was available to 92.9% of respondents. 
The cost of 1 years’ worth of immunosuppression was not known to 82.1% of 
respondents. The cost was thought to be > $20 000 per year amongst those (17.9%) 
who did estimate the cost. Antivirals in the form of antiretrovirals (92.3%) and 
acyclovir (89.3%) were widely available however valganciclovir (46.4%) was 
available to less than half of the respondents. (Table 5: Drug availability to support 
transplantation) 
 
Table 5: Drug availability to support transplantation 
 
Immunosuppression Available Not available 
Methylprednisolone 22 (78.6%) 5 (17.9%) 
Cyclosporin 21 (75%) 6 (21.4%) 
Tacrolimus 18 (64.3%) 9 (32.1%) 
Azathioprine 20 (71.4%) 7 (25%) 
Mycophenolate mofetil 21 (75%) 6 (21.4%) 
Mycophenolic acid 11 (39.3%) 16 (57.1%) 
Anti-thymocyte globulin 4 (14.3%) 23 (82.1%) 
Thymoglobulin 2 (7.1%) 25 (89.3%) 
Rituximab 3 (10.7%) 24 (85.7%) 
Antivirals   
Antiretrovirals (HIV) 26 (92.3%) 1 (3.6%) 
Acyclovir 25 (89.3%) 2 (7.1%) 
Valganciclovir 13 (46.4%) 14 (50%) 
Donor specific antibody management   
Plasmapheresis 26 (92.9%) 1 (3.6%) 
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Protocols    
Immunosuppression protocols in place 17 (60.7%) 9 (32.1%) 
- Cyclosporin predominant 
- Tacrolimus predominant 
8 (28.6%) 
9 (32.1%) 
Cost of immunosuppression Known Unknown 
For 1 year 5 (17.9%) 
Between $ 20 
- 30 000 
23 (82.1%) 
 
 
International support and collaboration 
 
Half of respondents reported a deficiency in surgeons, infrastructure and government 
support. While 14.3% reported that surgeons alone were the greatest need, 7.1% 
cited infrastructure support alone, and 28.6% said only government support was 
lacking. Respondents were split as the preferred method of international 
collaboration, between visiting foreign experts (42.9%) and travelling abroad for 
training (46.4%). Three (10.7%) of respondents were in favour of completing a 
foreign specialization. (Table 6: Needs and preferred method of international 
collaboration) 
 
Table 6: Needs and preferred method of international collaboration 
 
Perceived Deficiency in System  
Surgeons 4 (14.3%) Total 18 
Infrastructure 2 (7.1%) Total 16 
Government support 8 (28.6%) Total 22 
All of the above deficient 14 (50%) 
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Preferred method of collaboration  
Visiting experts 12 (42.9%) 
Training at a foreign centre 13 (46.43%) 
Foreign specialization 3 (10.7%) 
 
* 23 of the 28 respondents had received some training outside of their home country. 
 
 
Funding source for dialysis, transplantation and immunosuppression 
 
The private funding was the sole source for dialysis (64.3%), transplantation (57.1%) 
and immunosuppression (75%) access. The state was the sole funding source 
available to the patients for 10% of respondents. A combination of private or state 
funding sources were available to a quarter of the patients for haemodialysis and 
transplantation. (Table 7: Funding source for dialysis, transplantation and 
immunosuppression) 
 
Table 7: Funding source for dialysis, transplantation and immunosuppression 
 
Treatment State State and 
Private 
Private 
Haemodialysis  3 (10.7%) 7 (25.0%) 18 (64.3%) 
Transplantation 4 (14.3%) 8 (28.6%) 16 (57.1%) 
Immunosuppression 3 (10.7%) 4 (14.3%) 21 (75.0%) 
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Laws and Legal Regulations 
 
Only Kenya, Nigeria, Rwanda, Sudan and Tunisia had legislation covering organ 
donation and transplantation. In Ethiopia and Ghana legislation was under 
development. Most doctors were unsure of the legal status of brain death in their 
country. In Rwanda, Sudan and Tunisia there is legislation regarding the declaration 
of brain death. In practice however brain death was accepted in more countries 
(Cameroon, Kenya and Zambia) despite there being no legislation in those countries. 
Laws against giving or receiving payment for organs did exist in all countries except 
Malawi and Cameroon. On further questioning formal penalties existed for 
commercialization of transplants in 5 countries: Ethiopia, Ghana, Rwanda, Sudan 
and Tunisia. Rwanda was the only country with formal arrangements to allow 
transplants to take place abroad. Malawi allowed travel for transplant on an ad hoc 
basis. Only Tunisia had laws in place governing the transplantation of foreigners 
within their borders. (Table 8: Laws and legal regulations) 
 
Table 8: Laws and legal regulations 
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Legislation covering organ 
donation and 
transplantation 
N D D Y - Y Y Y Y N 
Legislation regarding 
declaration of brain death 
- - N - - - Y Y Y - 
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Acceptable for death to be 
declared upon irreversible 
cessation of brain/brain-
stem functions 
Y - N Y - Y Y N Y Y 
Acceptable for death to be 
declared upon irreversible 
cessation of cardio-
respiratory function 
Y - Y - - Y N Y N Y 
Laws against giving or 
receiving payment for 
organs 
- Y Y Y - Y Y Y Y Y 
Penalties associated for 
commerce with organs 
- Y Y - - N Y Y Y - 
Prohibition of organ 
trafficking   
Y Y D Y - N Y Y Y N 
Patient confidentiality Y N Y Y - Y N Y Y Y 
Agreements to allow 
patients to be transplanted 
abroad 
N N N N Ad 
hoc 
N Y N N N 
Agreements to allow 
foreigners to be 
trasnplanted 
N N N N N N N N Y N 
 
“Y” = Yes, “N” = No, “D” = Draft stage, “-“ = Unknown 
 
Dialysis and transplantation activity 
 
There was marked variability in access to dialysis across the countries participating. 
Tunisia and Sudan had large dialysis programs with 8962 and 6067 patients 
respectively. All countries had some government / public dialysis service except for 
Ethiopia where all dialysis occurred in the private sector. Most dialysis was in the 
form of haemodialysis with no countries other than Tunisia (250 patients) and Sudan 
(100 patients) having more than 10 patients on peritoneal dialysis. 
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Four countries Cameroon, Ethiopia, Malawi and Zambia had no transplant centres. 
Kenya, Nigeria, Sudan and Tunisia had more than 5 transplant centres each. Apart 
from Kenya where four centres were in the private sector the majority of centres in 
Nigeria, Sudan and Tunisia were in the public sector. Ghana and Rwanda each had 
a single transplant centre. Local transplant activity was limited with only Sudan and 
Tunisia performing over 100 transplants. Rwanda had yet to perform a transplant in 
their centre. All countries had patients travelling for transplants outside of their 
country. There was no deceased organ donation taking place in any of the countries 
and no heart or liver transplantation activity reported. (Table 9: Country Dialysis and 
Transplant Activity Breakdown 2012) 
 
Table 9: Country Dialysis and Transplant Activity Breakdown 2012 
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Population 
(millions) 
20.5 86.5 24 42 15.5 160 11 31 10.8 13 
Patients 
on dialysis 
497 150 300 803 37 1502 64 6067 8962 50 
  Public  495 0 300 451 19 1000 64 6067 2825 40 
  Private 2 150 0 352 18 502 0 0 6137 10 
Patients 
on waiting 
list 
0 0 15 39 0 1500 36 156 1153 0 
Transplant 
Centres 
0 0 1 5 0 8 1 6 6 0 
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  Public  0 0 1 1 0 6 1 5 6 0 
  Private 0 0 0 4 0 2 0 1 0 0 
Living 
donor 
transplant 
0 0 3 60 0 14 0 165 122 0 
  Public  0 0 3 33 0 6 0 134 122 0 
  Private 0 0 0 27 0 8 0 31 0 0 
Patients 
travelled 
abroad for 
transplant 
3 26 3 10 0 150 11 90 3 9 
 
 
Barriers to Living Donor Transplantation 
 
For living donor transplantation, the largest barrier to was assessed to be cost. 
Infrastructure for appropriate donor and recipient matching and securing a consistent 
supply of immunosuppressive drugs were the next largest obstacles identified. 
Institutional support for living donor transplantation did not seem to be lacking with 
the infrastructure already in place for handling the cases in theatre and supporting 
patients pre and post operatively. In Nigeria, Zambia and Malawi cultural and 
religious attitudes towards organ donation and transplantation were a concern for the 
respondents. (Table 10: Barriers to living donor organ transplantation) 
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Table 10: Barriers to living donor organ transplantation (Participant ranking of 
barriers to successful graft management, from least important (1) to most important 
(10).) 
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Average 
rank 
Ability of patients to meet cost . 10 6.5 2.3 4 8.3 8 1 1 10 7.7 
Resources to perform 
screening and donor recipient 
crossmatching 
2 9.5 6.5 6.5 6 5.9 6 1  1 9 6.1 
Consistent supply of 
immunosuppressive drugs 
. 4 3.5 6.8 8 7.0 1 1 1 7.3 5.9 
Cultural or religious attitudes 
toward organ donation and 
transplantation 
2 2 2 2.8 7 4.3 1 1 2 6 3.6 
Availability of suitable living 
donors 
2 2 2.5 2.8 5 3.9 1 9 2 4 3.5 
Awareness of medical 
professionals 
. 5 3.5 5.3 4 2.6 3 1 2 4.3 3.4 
Appropriate pre- and post- 
operative care 
. 6.5 1.5 4 5 2.2 1 1 2 5.7 3.1 
Ability to provide appropriate 
in theatre care 
. 6.5 1.5 3.5 3 2.4 1 1 2 5 3 
Support for the practice at 
your institution 
1 5.5 1.5 2.5 3 2.6 1 6 2 3.7 2.9 
 
 
Barriers to deceased Donor Transplantation 
 
For deceased donation cost was the major obstacle assessed in most countries. 
Legal issues were also a significant concern for all countries except Rwanda and 
Tunisia. The logistics of transplantation such as matching and allocation  
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It was felt that there was less institutional support for deceased donation than living 
donation. Religious and cultural objections were also felt to be more of an issue with 
deceased donation. ICU resource constraints and education of medical professionals 
in identifying potential donors were other impediments highlighted. In Tunisia the 
lack of ICU physicians willing to identify and refer donors was seen as the major 
factor limiting deceased donation. (Table 11: Barriers to Deceased Donation and 
Transplantation) 
 
Table 11: Barriers to Deceased Donation and Transplantation (Participant 
ranking of barriers to successful graft management, from least important (1) to most 
important (10).) 
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Average 
rank 
Ability of patients to meet 
costs 
. 9.5 5.5 7.7 3 8.7 1 2 1 9.7 7.5 
Legal issues . 5.5 8.5 7.3 7 8.2 1 2 1 6.7 7 
Availability of resources 
to perform donor 
screening and donor -
recipient crossmatching 
. 10 8 7 7 6 6 4 1 9.7 6.8 
Ability to co-ordinate 
deceased donation and 
organ allocation 
. 10 6.5 8.7 9 5.6 10 3 1 7.3 6.6 
Level of organization and 
coordination of services 
. 10 4.5 9.7 6 5.5 10 6 8 5 6.5 
Cultural or religious 
attitudes 
. 10 6 8 7 6 1 3 7 6.7 6.4 
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Consistent supply of 
immunosuppressive 
drugs 
. 5 4 6 8 6.7 1 4 1 7.3 5.9 
Identification of deceased 
donors 
. 8.5 5 5 10 4.2 4 6 4 9 5.5 
Critical care capabilities . 10 7.5 4.3 9 4.4 1 4 6 7 5.4 
Availability of suitable 
deceased donors 
. 9.5 6.5 2.3 10 3.4 4 2 7 6 4.6 
Awareness of medical 
professionals 
. 8.5 6.5 5 8 3.3 3 2 8 3.7 4.5 
Support at your institution . 5.5 4 3.7 3 3.2 10 6 6 3 3.9 
Willingness of ICU 
physicians to participate 
in organ donation 
. 9 6.5 2.7 7 2 5 2 8 5.7 3.9 
Ability to provide 
appropriate in theatre care 
. 6.5 2.5 3.3 3 2.4 1 1 2 5.3 3 
Ability to provide 
appropriate pre- and post-
operative care 
. 6.5 2.5 3.3 4 2 1 1 1 5.7 2.8 
 
 
Barriers to Successful Transplant Outcomes 
 
Cost was seen as the major barrier to good transplant outcomes. The risk of 
infectious disease complications while acknowledged was not felt to be as major an 
issue as laboratory and pathology resources or consistent supply of 
immunosuppressive drugs. (Table 12: Barriers to Good Transplant Outcomes) 
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Table 12: Barriers to Good Transplant Outcomes (Participant ranking of barriers 
to successful graft management, from least important (1) to most important (10).) 
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Average 
rank 
Ability of patients to meet 
costs associated with 
transplantation 
. 9.5 6.5 8 3 7.9 3 4 1 8.7 7.3 
Availability of imaging 
pathology and 
histocompatibility labs 
. 9.5 3.5 7 7 6.4 3 9 1 5.7 6.2 
Consistent supply of 
immunosuppressive drugs 
. 4 4 6 7 7.1 1 2 1 7.3 5.9 
Risk of infectious disease 
post-transplantation 
. 7.5 3.5 3.5 6 5.2 2 9 6 6.3 5.2 
Ability to provide 
physician-orientated care, 
incl. drug levels and long-
term follow-up 
. 9 2.5 4.3 6 4.8 1 2 1 6.3 4.7 
Patient compliance with 
immunosuppressive drugs 
. 3.5 3 4 6 5.3 2 1 3 4 4.3 
Burden of comorbid 
disease in the population 
. 2 3 5 6 4.3 1 5 3 4.7 4.1 
 
 
Barriers to Organ Donation and Transplantation 
 
The major barrier seen by clinicians in the transplant field throughout Africa was the 
lack of histocompatibility testing facilities this was followed by the cost of 
immunosuppressive drugs. The need for a donor transplant registry was also 
identified as a significant barrier. This was highlighted the major need in Tunisia 
together with institutional support. Overall surgical training was noted to be more of a 
 48 
 
barrier than nephrology training. This was the most important concern for Rwanda. 
(Table 13: Barriers to Transplantation in General) 
 
Table 13: Barriers to Transplantation in General (Participant ranking of barriers to 
successful graft management, from least important (1) to most important (10).) 
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Average 
rank 
Histocompatibility testing . 10 6.5 7.5 8 7.1 7 9 1 9.3 7.5 
Cost of 
immunosuppressive drugs 
. 8 8 6 8 8.1 5 4 1 9.3 7.4 
Construction of a donor 
transplant registry 
. 10 3.5 6 9 8.4 1 2 9 6.3 7.1 
Surgical training . 10 6 8 7 4.6 10 6 1 7.7 6.2 
Legal protection for 
physicians and surgeons 
. 6 4 4.3 5 7.8 1 3 1 7 6 
Educational needs . 9.5 2.5 7.5 7 5.1 5 9 5 7 6 
Protocol and guidelines . 10 2 1.8 5 4.2 1 5 3 5.7 4.1 
Nephrology training . 9.5 2 4.5 7 3.3 1 6 1 2.7 3.9 
Institutional support . 5.5 3.5 2.8 4 2.5 1 3 9 3.3 3.2 
 
 
DISCUSSION 
 
Africa has a pressing need to develop organ donation and transplantation services to 
allow effective treatment of patients with irreversible end organ failure. A logical 
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starting point is renal transplantation as patients can be maintained on dialysis while 
awaiting transplant and the burden of disease is so great. Living donors and 
deceased donors (both DBD and DCD) are potential sources for donated kidneys 
with established international protocols in ethical practices and protections for living 
donors / work-up and follow-up of living donors. In our study representatives of 
African countries representing 414.3 million people gave insight into challenges 
facing the provision of transplantation in their country. 
 
 
Unfortunately, there are many challenges to overcome before transplantation can be 
readily available. These challenges vary greatly between countries on a continent of 
a billion people. Adequate resource allocation to health care systems is essential 
and has begun to improve as the GDP of various countries gets better. There is 
however a lack of good data to inform government policies and a lack of governance 
systems and legislation in place. Only half of the countries (Kenya, Nigeria, Rwanda 
and Sudan) had legislation covering organ donation and transplantation.  
 
Drives to create renal registries across Africa would greatly help to inform policy and 
resource allocation.(101) Tunisia was the most advanced country in terms of an 
effective registry of dialysis patients.(83) and with a central coordinating authority for 
transplantation activity was the most advanced country in renal transplants per 
million population. 
 
There are limited academic publications from many African countries. Scholarship 
should go hand in hand with the development of new medical services and may be 
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especially needed in areas with limited government oversight. Tunisia had the most 
scientific publications (n=28) when conducting the literature review for this study.  
 
The need for targeted approaches for each country to improve was apparent with 
countries’ transplant programs being at various stages of development. All countries 
reported patients travelling abroad in 2012 for transplantation except Malawi. It is 
essential that all countries have national transplant programs governed by rigorous 
regulations to ensure equitable access to transplantation services. The inability of 
countries to meet the transplantation needs of their population is identified as a 
major driver for organ trafficking. (3) This is paramount for deceased donation where 
the whole population needs to have the potential to benefit from a donor as the 
donor pool is considered to be that whole population. In Nigeria a mistrust of the 
health care system was a major reason for people not to donate.(59) Scientific 
reports related to organ trafficking have come from Sudan (57 asylum seekers to 
Egypt had sold organs) and Tunisia (20 patients travelled to Iraq, Egypt and Pakistan 
for transplantation) (78) 
 
Studies on public opinion towards organ donation were few. Cultural, religious and 
knowledge deficits were revealed across all countries where such studies have been 
performed (Ghana, Kenya and Nigeria).(39, 40, 47, 58-62) In Kenya the only such 
study looked only at attitudes towards xenotransplantation.(47) No published reviews 
of attitudes towards organ donation were found from the other countries. The lack of 
knowledge and support was not only in the general public but also shown among 
health care professionals and first-degree relatives there was a low rate of support of 
support for organ donation in Ghana (only 41% after brain death).(39) An awareness 
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of transplantation as a therapeutic modality was relatively unknown amongst 
healthcare professionals in Nigeria (only 60% were aware of renal transplantation as 
a treatment option).(62) Even in countries where support for organ donation is high 
such as the United States (95%) consent rates to donation are lower than the 
support rate. This must be a concern in Africa where public awareness and 
healthcare professional awareness is at much lower levels. 
 
Respondents in our study were well qualified with the majority being locally educated 
and with postgraduate qualifications but having travelled abroad for further training. 
92% had teaching positions but salary levels were low with 60.7% earning less that 
$1500 per month and 42.9% doing private work to subsidize their income. The ability 
to create an environment to retain medical staff (salary, living and working 
conditions, access to medical technology, and stable political environment) is 
important as “brain drain” from developing to developed countries is acknowledged 
as contributing more harm than good to developing countries.(102) 
 
Surgeons, nephrologists and anaesthetists were present in all institutions. And while 
nursing specialization in nephrology existed at most centres, nurses trained in ICU 
specialization and transplant coordination was more lacking. 
 
Hospital resources varied widely but core components to the surgical delivery of 
transplantation was available in all countries. The most pressing infrastructure 
resource need to ensure good transplant outcomes was HLA tissue typing facilities. 
The cost of immunosuppressive drugs considered to be the second most significant 
barrier to transplantation. Coupled to that immunosuppressive drug availability was 
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also shown to be limited. Only 75% had access to cyclosporin and 64.5% to 
tacrolimus. Over 80% of respondents did not have access to T cell therapy (Anti T-
cell lymphocytes or thymoglobulin) although 92.3% could access plasmapheresis.  
 
International collaborations are occurring on the African context and assist with skills 
transfer and development. However the scalability of these projects is limited and 
dependent on local financing and support to ensure that the effort is build into 
something more sustainable. On the African continent itself South Africa is in an 
excellent position to share expertise with the rest of Africa in the field of 
transplantation. 
 
Limitations 
 
This study is limited by the quality of its data, in that it is from selected individuals 
from certain institutions in selected African countries. The reproducibility of this study 
would be challenging as the questionnaires were administered at the 25th Southern 
African Transplantation Society Congress and Global Alliance for Transplantation 
Workshop in Durban, a non-recurring meeting, funded by a grant from the 
Transplantation Society. Analysing the data we have used both individual 
respondent data and pooled other data for country specific issues. As this is a 
descriptive study aiming to highlight needs in Africa, rather than an exhaustive 
analysis of individual needs for specific centres, and the data was so heterogenous, 
we have performed only this limited analysis. Further, more rigorous research is 
needed on this pressing health need.  Country specific research, in terms of 
legislation, cultural acceptance of organ donation and transplantation, logistical and 
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resource considerations, to fuel an academic, public and political discourse on 
improving transplantation in Africa is needed. While surveys of local experts, as in 
our study, offer a basic overview or description of what is happening within a specific 
country, use of other study methodologies, for example, use of registry data would 
inform improvement efforts and public policy more effectively.  The number of 
participants from Nigeria does bias the interpretation of individual responses 
however it is a large country (160 million people) and respondents were from a 
number of different institutions and from different specialities. 
 
 
 
 
Conclusion 
 
The expansion of organ donation and transplantation in Africa faces many 
challenges. Large numbers of patients in many African countries do not have access 
to organ transplantation as a therapeutic option. This is reflective of large challenges 
to the health care systems in general. Legislative gaps and inadequate health care 
resources (financial constraints) are the main rate limiting steps. International 
assistance is welcome yet systems for health resource motivation and good 
governance needs to be created from within each country. 
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APPENDIX 5 – Per country analysis of dialysis and transplant activity in 2012 
See overleaf – 2 countries per page 
79 
Cameroon 
Population (millions) 20.5 
Patients on dialysis 497 
  Public 495 
  Private 2 
Patients on waiting list 0 
Transplant Centres 0 
  Public 0 
  Private 0 
Living donor transplants 0 
  Public 0 
  Private 0 
Patients travelled abroad for transplant 3 
Ethiopia 
Population (millions) 86.5 
Patients on dialysis 150 
  Public 0 
  Private 150 
Patients on waiting list 0 
Transplant Centres 0 
  Public 0 
  Private 0 
Living donor transplants 0 
  Public 0 
  Private 0 
Patients travelled abroad for transplant 26 
80 
Ghana 
Population (millions) 24 
Patients on dialysis 300 
  Public 300 
  Private 0 
Patients on waiting list 15 
Transplant Centres 1 
  Public 1 
  Private 0 
Living donor transplants 3 
  Public 3 
  Private 0 
Patients travelled abroad for transplant 3 
Kenya 
Population (millions) 42 
Patients on dialysis 803 
  Public 451 
  Private 352 
Patients on waiting list 39 
Transplant Centres 5 
  Public 1 
  Private 4 
Living donor transplants 60 
  Public 33 
  Private 27 
Patients travelled abroad for transplant 10 
81 
Malawi 
Population (millions) 15.5 
Patients on dialysis 37 
  Public 19 
  Private 18 
Patients on waiting list 0 
Transplant Centres 0 
  Public 0 
  Private 0 
Living donor transplants 0 
  Public 0 
  Private 0 
Patients travelled abroad for transplant 0 
Nigeria 
Population (millions) 160 
Patients on dialysis 1502 
  Public 1000 
  Private 502 
Patients on waiting list 1500 
Transplant Centres 8 
  Public 6 
  Private 2 
Living donor transplants 14 
  Public 6 
  Private 8 
Patients travelled abroad for transplant 150 
82 
Rwanda 
Population (millions) 11 
Patients on dialysis 64 
  Public 64 
  Private 0 
Patients on waiting list 36 
Transplant Centres 1 
  Public 1 
  Private 0 
Living donor transplants 0 
  Public 0 
  Private 0 
Patients travelled abroad for transplant 11 
Sudan 
Population (millions) 31 
Patients on dialysis 6067 
  Public 6067 
  Private 0 
Patients on waiting list 156 
Transplant Centres 6 
  Public 5 
  Private 1 
Living donor transplants 165 
  Public 134 
  Private 31 
Patients travelled abroad for transplant 90 
83 
Tunisia 
Population (millions) 10.8 
Patients on dialysis 8962 
  Public 2825 
  Private 6137 
Patients on waiting list 1153 
Transplant Centres 6 
  Public 6 
  Private 0 
Living donor transplants 122 
  Public 122 
  Private 0 
Patients travelled abroad for transplant 3 
Zambia 
Population (millions) 13 
Patients on dialysis 50 
  Public 40 
  Private 10 
Patients on waiting list 0 
Transplant Centres 0 
  Public 0 
  Private 0 
Living donor transplants 0 
  Public 0 
  Private 0 
Patients travelled abroad for transplant 9 
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